The first of its kind, Lycagel is made up of pea starch technology.
On Nov. 18, 2020, Roquette, a French plant-based ingredients company and pharmaceutical excipients provider, announced the launch of its pea starch technology, Lycagel, for vegetarian softgel capsule formulations.
The first of its kind, according to the company, the new capsule formulation is made up of carrageenan, a setting agent found in marine macro algae, NEOSORB sorbitol, a plant-based ingredient used for nutraceutical applications, and salt, a company press release said. The new product offers significant capsule strength, seal integrity, quick drying time with no stickiness, fast disintegration, no cross-linking, and higher processing temperature suitability.
“The launch of L[ycagel] marks a new era for softgel formulations and manufacturing. Manufacturers no longer need to compromise on performance when launching a vegetable softgel solution,” said Paul Smaltz, head of Roquette’s Global Pharmaceutical business unit, in the press release. “Designed to be easily adaptable to existing gelatin processes, Lycagel can support businesses in bringing vegetarian alternatives to market quickly, without significant changes to existing operations.”
Source: Roquette
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Drug Manufacturing Technology
April 5th 2022In this episode of the Drug Solutions Podcast, Jennifer Markarian, manufacturing reporter, talks about continuous manufacturing of oral solid-dosage drugs with Lawrence De Belder, executive consultant at Pharmatech Associates, a USP company.